Investor Resources will be posted here very soon. If you would like more information, please email email@example.com
BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits
the unique microenvironment of diseased tissue to more effectively target cancer.